United Therapeutics | UTHR - Operating Profit



United Therapeutics reported $276.9M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Amarin USD -16755000 35.77M Mar/2025
Ardelyx USD -14400000 22.52M Jun/2025
Baxter International USD 272M 214M Jun/2025
Bayer EUR 13M 2.31B Jun/2025
Biogen USD 851.8M 540.6M Jun/2025
BioMarin Pharmaceutical USD 276.89M 52.99M Jun/2025
Gilead Sciences USD 2.7B 467M Jun/2025
GlaxoSmithKline GBP 2.02B 193M Jun/2025
Halozyme Therapeutics USD 202.44M 60.91M Jun/2025
Insmed USD -253876000 5.74M Jun/2025
Ionis Pharmaceuticals USD 139.84M 285.84M Jun/2025
J&J USD 6.94B 6.69B Jun/2025
Moderna USD -907000000 143M Jun/2025
Pfizer USD 2.6B 1.06B Jun/2025
PTC Therapeutics USD -34858000 1.01B Jun/2025
Regeneron Pharmaceuticals USD 1.08B 487.8M Jun/2025
Sarepta Therapeutics USD 115.58M 415.96M Jun/2025
Teva Pharmaceutical Industries USD 899M 380M Jun/2025
United Therapeutics USD 276.9M 105.9M Jun/2025
Vertex Pharmaceuticals USD 1.15B 123.1M Jun/2025